Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome

Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome

Item
http://www.wikidata.org/entity/Q34360485
Effects of vitamin E on cognitive performance during ageing and in Alzheimer's diseaseElevated Autophagy and Mitochondrial Dysfunction in the Smith-Lemli-Opitz Syndrome.Selected biomarkers as predictive tools in testing efficacy of melatonin and coenzyme Q on propionic acid - induced neurotoxicity in rodent model of autism.Pathogenesis, Epidemiology, Diagnosis and Clinical Aspects of Smith-Lemli-Opitz Syndrome.Fibroblasts from patients with major depressive disorder show distinct transcriptional response to metabolic stressors.Free radical oxidation of cholesterol and its precursors: Implications in cholesterol biosynthesis disorders.Inhibitors of 7-Dehydrocholesterol Reductase: Screening of a Collection of Pharmacologically Active Compounds in Neuro2a Cells.Identification of Environmental Quaternary Ammonium Compounds as Direct Inhibitors of Cholesterol Biosynthesis.Reactivities and products of free radical oxidation of cholestadienols.Oxidative stress, serotonergic changes and decreased ultrasonic vocalizations in a mouse model of Smith-Lemli-Opitz syndrome.Cholecalciferol synthesized after UV-activation of 7-dehydrocholesterol onto titanium implants inhibits osteoclastogenesis in vitro.Antioxidants: The Missing Key to Improved Therapeutic Intervention in Smith-Lemli-Opitz Syndrome?Birthday of a syndrome: 50 years anniversary of Smith-Lemli-Opitz Syndrome.Effect of psychotropic drug treatment on sterol metabolism.Prevention of Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome.7-Dehydrocholesterol (7-DHC), But Not Cholesterol, Causes Suppression of Canonical TGF-β Signaling and Is Likely Involved in the Development of Atherosclerotic Cardiovascular Disease (ASCVD).Altered cerebrospinal fluid proteins in Smith-Lemli-Opitz syndrome patients.
P2860

Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome

Item
http://www.wikidata.org/entity/Q34360485
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome
@ast
Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome
@en
Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome
@nl
type
label
Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome
@ast
Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome
@en
Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome
@nl
prefLabel
Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome
@ast
Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome
@en
Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome
@en
P2093
P2860
P304
P31
P356
10.1016/J.BIOPSYCH.2013.06.013
P407
P433
P478
P577
P5875
P698
P932